Reflux treatments reduce risk of esophageal cancer

GERD affects 10% to 20% of adults in Western populations and has been known to be an increased risk factor for esophageal adenocarcinoma. Research on the association between antireflux medication or surgery and risk for esophageal adenocarcinoma has remained limited, although the typical approach has been to treat reflux aggressively when there are precancerous changes like

Liver Frailty Index Predicts Mortality Risk

The Liver Frailty Index can give physicians better data about the mortality risk of cirrhosis patients than just subjective data, according to a study led by Dr. Jennifer Lai of the University of California at San Francisco. In the study, published in The American Journal of Gastroenterology, 529 patients were tested on grip strength, balance

Patient-to-patient support very beneficial

While using the internet for a diagnosis is not recommended, there’s great power in finding other patients willing to share their own stories. Doctors may be too busy to properly inform or empathize on the level that patients need to hear. They may speak at a technical level well out of reach for most. Besides,

Liver transplants for HCV cirrhosis on the decline

A retrospective study in the journal Liver International found use of direct-acting antivirals may be associated with the reduced number of patients on a waiting list for a liver transplant for decompensated hepatitis C virus cirrhosis. Researchers found an increase in HCV patients whose indication for liver transplant was hepatocellular carcinoma during the study period,

Entyvio safe and effective for UC in real-world study

An analysis of data from the VICTORY consortium through the University of California at San Diego, as published in The American Journal of Gastroenterology, found vedolizumab effective in ulcerative colitis. Cumulative rates of endoscopic remission and clinical remission were the main effectiveness outcomes of the review. Researchers analyzed secondary outcomes measures of cumulative rates of

49% of Americans are concerned about healthcare data security

Almost half of Americans are extremely or very concerned about their healthcare data security, such as diagnoses, health history, and test results, according to a survey of more than 2,000 US adults by The Harris Poll on behalf of healthcare marketing firm Scout. The survey also found that US adults are most concerned about previously diagnosed medical

Study Supports Safety of Infliximab in Pregnancy

An analysis of data from the TREAT Registry found that babies born to women who continued to treat their Crohn’s disease with infliximab during pregnancy had outcomes similar to those who did not take the drug. “The majority of both maternal pregnancies and partner outcomes resulted in live births of healthy infants across exposure groups”